These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 17371428

  • 1. Risk factors for breast cancer in Turkish women: a hospital-based case-control study.
    Beji NK, Reis N.
    Eur J Cancer Care (Engl); 2007 Mar; 16(2):178-84. PubMed ID: 17371428
    [Abstract] [Full Text] [Related]

  • 2. Menstrual factors in relation to breast cancer risk.
    Titus-Ernstoff L, Longnecker MP, Newcomb PA, Dain B, Greenberg ER, Mittendorf R, Stampfer M, Willett W.
    Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):783-9. PubMed ID: 9752986
    [Abstract] [Full Text] [Related]

  • 3. Coffee consumption and the risk of breast cancer.
    Tavani A, Pregnolato A, La Vecchia C, Favero A, Franceschi S.
    Eur J Cancer Prev; 1998 Feb; 7(1):77-82. PubMed ID: 9511854
    [Abstract] [Full Text] [Related]

  • 4. Risk factors for breast cancer: a hospital-based case-control study.
    Kocic B, Petrovic B, Filipovic S.
    J BUON; 2008 Feb; 13(2):231-4. PubMed ID: 18555470
    [Abstract] [Full Text] [Related]

  • 5. Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women.
    Nichols HB, Trentham-Dietz A, Love RR, Hampton JM, Hoang Anh PT, Allred DC, Mohsin SK, Newcomb PA.
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):41-7. PubMed ID: 15668474
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Risk of breast cancer in post-menopausal women using hormone replacement therapy.
    Ratanawichitrasin A, Reansuwan W, Ratanawichitrasin S, Bhodhisuwan K, Kongpatanakul S.
    J Med Assoc Thai; 2002 May; 85(5):583-9. PubMed ID: 12188389
    [Abstract] [Full Text] [Related]

  • 8. Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years.
    Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Marchbanks PA, Coates RJ, Norman SA, Weiss LK, Ursin G, Burkman RT, Deapen D, Folger SG, McDonald JA, Simon MS, Strom BL, Spirtas R.
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1175-81. PubMed ID: 14652277
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dietary carotenoids and risk of breast cancer in Chinese women.
    Huang JP, Zhang M, Holman CD, Xie X.
    Asia Pac J Clin Nutr; 2007 Nov; 16 Suppl 1():437-42. PubMed ID: 17392146
    [Abstract] [Full Text] [Related]

  • 11. Risk of breast cancer associated with short-term use of oral contraceptives.
    Folger SG, Marchbanks PA, McDonald JA, Bernstein L, Ursin G, Berlin JA, Daling JR, Norman SA, Strom BL, Weiss LK, Simon MS, Burkman RT, Malone KE, Spirtas R.
    Cancer Causes Control; 2007 Mar; 18(2):189-98. PubMed ID: 17216547
    [Abstract] [Full Text] [Related]

  • 12. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
    Shantakumar S, Terry MB, Paykin A, Teitelbaum SL, Britton JA, Moorman PG, Kritchevsky SB, Neugut AI, Gammon MD.
    Am J Epidemiol; 2007 May 15; 165(10):1187-98. PubMed ID: 17337757
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lifetime physical activity and the risk of breast cancer: a case-control study.
    Kruk J.
    Cancer Detect Prev; 2007 May 15; 31(1):18-28. PubMed ID: 17296272
    [Abstract] [Full Text] [Related]

  • 15. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
    Quick SK, Shields PG, Nie J, Platek ME, McCann SE, Hutson AD, Trevisan M, Vito D, Modali R, Lehman TA, Seddon M, Edge SB, Marian C, Muti P, Freudenheim JL.
    Cancer Epidemiol Biomarkers Prev; 2008 May 15; 17(5):1082-7. PubMed ID: 18483329
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. An analysis of the effect of selection bias on the association of hormone replacement therapy and breast cancer risk.
    Csizmadi I, Friedenreich CM, Bryant HE, Courneya KS.
    Chronic Dis Can; 2005 May 15; 26(2-3):73-9. PubMed ID: 16251013
    [Abstract] [Full Text] [Related]

  • 18. Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancer.
    Strom BL, Berlin JA, Weber AL, Norman SA, Bernstein L, Burkman RT, Daling JR, Deapen D, Folger SG, Malone KE, Marchbanks PA, Simon MS, Ursin G, Weiss LK, Spirtas R.
    Contraception; 2004 May 15; 69(5):353-60. PubMed ID: 15105056
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.